Case history {#s1}
============

A 55-year-old man was referred to the outpatient pulmonary department of our hospital because of dyspnoea during exertion and when bending forward, which had been present for at least 6 months. He reported experiencing severe symptoms of breathlessness and many of his daily activities had to be adapted or interrupt due to symptoms (as documented by the Baseline Dyspnea Index (BDI)) ([table 1](#TB1){ref-type="table"}). Recent infectious episodes or episodes of neck or shoulder pain were absent. His medical history included systemic arterial hypertension, obesity (body mass index (BMI) 36 kg·m^−2^), and obstructive sleep apnoea for which he was treated with night-time continuous positive airway pressure therapy (8 cmH~2~O). He was a former smoker (18 pack-years) who quit smoking 15 years ago. 8 months ago, he underwent abdominal surgery (transabdominal epigastric hernia repair). The presence of cardiopulmonary disease and other aetiologies, such as neuromuscular disease, was excluded. Chest radiograph showed an elevated left hemidiaphragm and impaired left phrenic nerve conduction (*i.e.* increased latency and compound muscle action potential (CMAP) duration) after electrical stimulation ([table 1](#TB1){ref-type="table"}) \[[@C1]\].

###### 

Demographic data, dyspnoea, lung function tests and phrenic nerve conductance assessments pre- and post-inspiratory muscle training (IMT)

                                            **Baseline (pre-IMT)**   **Post-IMT**   **Reference value**
  ----------------------------------------- ------------------------ -------------- ---------------------
  **Demographic data**                                                              
   Sex                                      Male                                    
   Age years                                55                                      
   Height cm                                187                                     
   Weight kg                                127                                     
   BMI kg·m^−2^                             36                                      
  **BDI, score/total score**                5/12                                    
  **Lung function**                                                                 
   FEV~1~ sitting L (% pred)                2.62 (62)                2.75 (65)      
   FVC sitting L (% pred)                   3.29 (60)                3.65 (68)      
   FEV~1~/FVC sitting %                     80                       75             
   FEV~1~ supine L (% pred)                 1.85 (44)                1.84 (44)      
   FVC supine L (% pred)                    2.50 (46)                2.61 (48)      
   FEV~1~/FVC supine %                      74                       70             
   ΔFVC sitting *versus* supine %           −24                      −28            
   MVV L·min^−1^ (% pred)                   98.3 (72)                103.1 (75)     
   IC L (% pred)                            3.07 (75)                3.33 (82)      
   TLC L (% pred)                           5.43 (69)                5.80 (74)      
   FRC L (% pred)                           2.36 (63)                2.47 (66)      
   RV L (% pred)                            1.89 (79)                2.12 (88)      
   *D*~LCO~ mmol·min^−1^·kPa^−1^ (% pred)   9.20 (83)                9.94 (89)      
  **Phrenic nerve conductance**                                                     
   Latency ms                                                                       8
    Right                                   7.6                      8.6            
    Left                                    15.4                     17.6           
   CMAP duration ms                                                                 15
    Right                                   8.9                      16             
    Left                                    21                       25             
   Amplitude mV                                                                     0.46
    Right                                   0.60                     0.60           
    Left                                    0.50                     0.20           

MVV: maximum voluntary ventilation; IC: inspiratory capacity; TLC: total lung capacity; FRC: functional residual capacity; RV: residual volume; *D*~LCO~: diffusing capacity of the lung for carbon monoxide. Reference values for phrenic nerve conductance based on \[1\].

During baseline assessments, upright forced vital capacity (FVC) was 60% of predicted, while the ratio between forced expiratory volume in 1 s and FVC (FEV~1~/FVC) was 80% \[[@C2]\]. Static lung volumes and capacities were also decreased \[[@C3]\]. Taken together the results of these assessments suggest a restrictive pulmonary function impairment without expiratory flow limitation. When the FVC manoeuvre was performed in the supine position, a reduction by 24% was observed relative to sitting without severe symptoms of orthopnoea occurring during the supine assessment ([table 1](#TB1){ref-type="table"}).

The maximal inspiratory (*P*~Imax~) and expiratory pressures (*P*~Emax~) were −108 cmH~2~O (97% predicted) and 213 cmH~2~O (176% predicted), respectively ([table 2](#TB2){ref-type="table"}) \[[@C4], [@C5]\].

###### 

Respiratory muscle strength assessment pre- and post-IMT

                                       **Baseline (pre-IMT)**   **Post-IMT**
  ------------------------------------ ------------------------ --------------
  *P*~Imax~ cmH~2~O (% pred)           −108 (97)                −133 (120)
  *P*~Emax~ cmH~2~O (% pred)           213 (176)                285 (236)
  Sniff *P*~oes~ cmH~2~O               −93                      −124
  Sniff *P*~ga~ cmH~2~O                −19                      −23
  Sniff *P*~di~ cmH~2~O (% pred)       74 (51)                  101 (69)
  Twitch *P*~di~ (right) cmH~2~O       6.4                      8.5
  Twitch *P*~di~ (left) cmH~2~O        2.4                      4.6
  Twitch *P*~di~ (bilateral) cmH~2~O   10.8                     12.7

Sniff *P*~oes~: oesophageal pressure during sniff manoeuvre; Sniff *P*~ga~: gastric pressure during sniff manoeuvre; Sniff *P*~di~: transdiaphragmatic pressure during sniff manoeuvre; Twitch *P*~di~: transdiaphragmatic pressure during bilateral phrenic nerve magnetic stimulation.

Based on these findings the diagnosis of unilateral diaphragm dysfunction (UDD) was made.

Question {#s2}
========

Could an inspiratory muscle training (IMT) programme, in this patient with almost normal *P*~Imax~, be indicated to improve diaphragm function and exertional dyspnoea?

Answer {#s3}
======

To answer this question, additional assessments were performed both before and after a 6-month IMT period.

Transdiaphragmatic pressure (*P*~di~) obtained during maximal voluntary sniff manoeuvres (sniff *P*~di~) was 74 cmH~2~O (51% predicted) ([table 2](#TB2){ref-type="table"} and [figure 1a](#F1){ref-type="fig"}) \[[@C5]\]. A sniff *P*~di~ of \<80 cmH~2~O is indicative of significant diaphragmatic weakness \[[@C6]\]. Bilateral magnetic phrenic nerve stimulation resulted in a twitch *P*~di~ of 10.8 cmH~2~O ([figure 1b](#F1){ref-type="fig"}). During unilateral stimulation the obtained twitch *P*~di~ values were 2.4 and 6.4 (for left and right stimulation, respectively) ([table 2](#TB2){ref-type="table"}). Twitch *P*~di~ values of \<20 cmH~2~O during bilateral stimulation or \<10 cmH~2~O during unilateral stimulation are indicative of significant diaphragmatic weakness \[[@C6]\]. In addition, a paradoxical response in gastric pressure (*P*~ga~) (*i.e.* negative relative to end-expiratory *P*~ga~) was observed during the maximal sniff manoeuvres (sniff *P*~ga~) ([table 2](#TB2){ref-type="table"} and [figure 1a](#F1){ref-type="fig"}).

![Illustration of *P*~di~, *P*~ga~ and *P*~oes~ pressure curves during a sniff manoeuvre a) pre- and b) post-IMT; and *P*~di~ during bilateral magnetic phrenic stimulation c) pre- and d) post-IMT.](EDU-0129-2019.01){#F1}

Furthermore, a maximal incremental (10 W·min^−1^) cardiopulmonary exercise test (CPET) (Vmax229d; SensorMedics, Yorba Linda, CA, USA) was performed on a cycle ergometer (Ergometrics 800S; SensorMedics). The patient achieved a peak work rate of 160 W (65% predicted), maximal oxygen consumption (*V′*~O~2~max~) of 20.8 mL·kg^−1^·min^−1^ (69% predicted) and a maximal heart rate of 140 beats per min (82% of predicted maximum) \[[@C7], [@C8]\]. The peak minute ventilation (*V*′~E~) was 59 L·min^−1^ (60% MVV). The patient rated the intensity of his perceived "breathing discomfort" (dyspnoea) and leg discomfort on a modified Borg scale (0--10) every minute during the test \[[@C9]\]. He indicated 9 for dyspnoea and 7 for leg effort at peak exercise and selected dyspnoea as the main reason (80% relative to 20% leg effort) for stopping the test.

A subsequent constant work rate (CWR) endurance cycling test was performed at 70% of the peak work rate achieved during the CPET. The duration of loaded cycling was 5 min and 30 s and, again, the main reason for stopping exercise was dyspnoea (80% relative to 20% leg effort). During the CWR test, a combined diaphragm electromyogram (EMG~di~)-electrode catheter with oesophageal and gastric balloons was used to assess the diaphragm activation (EMG~di~/EMG~di,max~), oesophageal (*P*~oes~), gastric (*P*~ga~) and transdiaphragmatic (*P*~di~) pressures \[[@C10]\]. In addition, surface EMG signals of scalene (EMG~sca~/EMG~sca,max~) and rectus abdominus (EMG~abd~/EMG~abd,max~) muscles were recorded. The EMG~di~/EMG~di,max~ and EMG~sca~/EMG~sca,max~ were expressed relative to maximal activation obtained during inspiratory capacity manoeuvres. The EMG~abd~/EMG~abd,max~ was expressed relative to the maximal activation obtained during the expiratory phase of a FVC manoeuvre \[[@C11]\]. The measures were assessed continuously and breath-by-breath measurements were averaged for each minute. At the end of the endurance test the EMG~di~/EMG~di,max~, EMG~sca~/EMG~sca,max~ and EMG~abd~/EMG~abd,max~ were 78%, 37% and 39%, respectively ([figure 2](#F2){ref-type="fig"} a--c). The *P*~di~, *P*~oes~ and *P*~ga~ swings were 35 cmH~2~O, −102 cmH~2~O and −68 cmH~2~O, respectively ([figure 2](#F2){ref-type="fig"} d--f). Of note, the *P*~ga~ swings were negative, indicating paradoxical *P*~ga~ responses during tidal (exercise) breathing.

![Percentage of maximal muscle activation of a) diaphragm (EMGdi/EMGdi, max), b) scalene (EMGsca/EMGsca, max), c) abdominal (EMGabd/EMGSabd, max) muscles, and d) *P*~di~, e) *P*~oes~ and f) *P*~ga~, during constant work rate exercise pre- and post-IMT. Dotted lines indicate the end of the endurance test for pre- and post-IMT. Red arrows indicate swing pressures pre-IMT and black arrows indicate swing pressures post-IMT.](EDU-0129-2019.02){#F2}

These additional assessments further supported the diagnosis of UDD, identified specific diaphragm weakness and quantified the degree of exertional dyspnoea.

Treatment {#s4}
=========

IMT was performed using an electronic tapered flow resistive loading device (POWERbreathe^®^KH1, HaB International Ltd., Southam, UK). The programme was based on a high intensity IMT protocol as described previously \[[@C11]--[@C13]\]. It consisted of two to three daily sessions of 30 full vital capacity inspirations (4--5 min per session), performed 7 days a week for 6 months. The patient was able to start the training against an external load of 45 cmH~2~O (peak pressure during inspiration, ∼40% *P*~Imax~), which was initially selected as the highest load that allowed him to perform nearly full vital capacity inspirations. Once a month supervised training at the outpatient clinic was performed. This allowed review of the stored data on quantity and quality of home-based training sessions and comparison of those data with the results obtained during the supervised session. Evaluated training parameters included average mean pressure generated per breath (cmH~2~O), average mean power per breath (W), average inspiratory volume per breath (L) and total external mechanical work of breathing per session (J) \[[@C14]\]. The training load was progressively increased over the course of the training period from 45 cmH~2~O up to 62 cmH~2~O. The patient was very motivated to perform his breathing exercises and the perceived improvement in symptoms during the initial weeks of his training period probably contributed to increase his motivation. He completed a total of 420 sessions over the 6-month period (2.3 sessions per day).

Post-IMT assessment {#s5}
===================

Lung function tests and phrenic nerve conductance {#s5a}
-------------------------------------------------

All lung volumes and capacities increased slightly after training. The differences in FVC between upright and supine performance were unchanged, indicating the persistence of UDD after the intervention period ([table 1](#TB1){ref-type="table"}). Phrenic nerve conduction tests also did not show evidence of improvements in any of the recorded parameters. This suggests the absence of spontaneous nerve recovery \[[@C15], [@C16]\] during the study period.

Respiratory muscle strength {#s5b}
---------------------------

Bilateral and unilateral twitch *P*~di~ (diaphragm muscle contraction) were still indicative of significant diaphragm weakness after IMT ([table 2](#TB2){ref-type="table"}). However, sniff *P*~di~ improved by 27 cmH~2~O. This improvement was mostly due to increases in *P*~oes~ (global inspiratory strength) during the inspiratory sniff manoeuvre (from −93 to −124 cmH~2~O). The inspiratory sniff *P*~ga~ remained paradoxical ([figure 1](#F1){ref-type="fig"}). *P*~Imax~ (global inspiratory strength) increased by 25 cmH~2~O achieving 120% of predicted normal values ([table 2](#TB2){ref-type="table"}). These results suggest that the improvements in inspiratory muscle function were not related to improvements in diaphragm contractility but mostly to improvements in non-diaphragmatic inspiratory muscles \[[@C5]\].

Symptoms {#s5c}
--------

A one-unit change in the transitional dyspnoea index focal score is considered clinically important \[[@C17]\]. After the intervention period the patient presented a change of +6 (out of scores that could range from −9 to +9). The patient reported that he could perform activities such as stair climbing at higher effort levels without breathlessness and that he could perform daily activities more vigorously with less interruptions and less symptoms of breathlessness.

Exercise capacity {#s5d}
-----------------

During the CPET the patient achieved the same peak work rate (160 W) and similar *V′*~O~2~max~ (20.6 mL·kg^−1^·min^−1^, 68% predicted) \[[@C8]\] in comparison to baseline assessments.

The endurance cycling test was repeated at the same work rate as at baseline. Exercise time increased from 6 to 20 min, thereby reaching the maximal pre-specified duration of the post-intervention test. The dyspnoea perception decreased from 9 to 2 at the timepoint at which the baseline test had to be interrupted by the patient ([figure 3](#F3){ref-type="fig"}). For a similar *V*′~E~ at iso-work rate during cycling, less diaphragm (EMG~di~/EMG~di,max~) and scalene (EMG~sca~/EMG~sca,max~) activation were observed to generate a similar inspiratory effort (*i.e.* inspiratory *P*~oes~ and *P*~di~) ([figures 2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}). This comparable inspiratory effort resulted in higher tidal volume and lower respiratory frequency throughout exercise ([figures 2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}). Both the reduction in the activation for a given inspiratory effort and improved mechanical response (slower and deeper breathing pattern) for a given inspiratory effort contributed to improve neuromechanical coupling. This probably contributed to reduce the intensity of perceived breathing discomfort (dyspnoea) during exercise \[[@C18]\]. In addition, inspiratory *P*~ga~ remained paradoxical during endurance cycling, indicating the persisting diaphragm defect.

![a) *V*′~E~, b) Respiratory rate, c) Borg score for dyspnoea, d) Peak inspiratory flow, e) tidal volume (*V*~T~) and f) Borg score for leg effort during constant work rate exercise pre- and post-IMT. Dotted lines indicate the end of the endurance test for pre- and post-IMT.](EDU-0129-2019.03){#F3}

On the expiratory side, a decrease in EMG~abd~/EMG~abd,max~ was observed post-IMT and both expiratory *P*~oes~ and *P*~ga~ swings decreased by about 50%, mainly due to the decrease in positive expiratory pressure generation ([figure 2](#F2){ref-type="fig"}). This reduced reliance on abdominal muscle recruitment for active expiration suggests decreased reliance on passive recoil forces during inspiration after the intervention \[[@C19]\].

Considering these results, we can conclude that, for this patient, the IMT programme was effective to reduce exertional dyspnoea without improving diaphragm function. Although the IMT did not affect isolated diaphragm function, the improvements in global inspiratory muscle function and breathing pattern during exercise decreased the symptoms, indicating that this patient has benefited from the IMT programme despite his almost normal baseline *P*~Imax~ and persistent UDD. In the initial assessment, the *P*~Imax~ measurement did not detect respiratory weakness. The *P*~Imax~ manoeuvre is a global measurement reflecting global inspiratory muscle strength (combined measurement of diaphragmatic and non-diaphragmatic inspiratory muscle strength). This fact reinforces the need for specific assessments of diaphragmatic strength to identify UDD. Twitch *P*~di~ is therefore the preferred assessment to confirm diagnosis of diaphragm weakness \[[@C5]\].

Additional discussion points {#s6}
============================

The patient self-reported that he had neither consciously increased sport participation nor his participation in physical activities at work or during leisure time during the study period. In line with this, the absence of changes in peak work rate and *V*~O~2~max~ during the incremental cycling test, and similar *V*′~E~ at a given work rate during the CWR endurance cycling test, make it unlikely that improvements in cardiopulmonary fitness might have contributed to his reductions in exertional dyspnoea symptoms. In addition, no changes in body weight were observed, excluding this factor as a contributor to improvements in respiratory muscle function and symptoms.

Given the patient\'s continuing motivation and the fact that we observed persisting improvements in both training parameters and respiratory muscle function it was collaboratively decided to continue with the IMT intervention after the 6-month study period. In case a plateau in the training parameters or decrease in motivation are observed, it can be decided to either reduce the frequency to once daily or once every 2 days while maintaining intensity (*i.e.* external load) in order to maintain benefits.

How the specific effects of IMT that were observed in this specific case relate to the general population of patients with UDD is unclear. Since symptoms vary according to clinical presentation, associated conditions and the possibility of spontaneous recovery in some cases, the respiratory muscle responses to training may also vary. Despite the promising findings in this case, further studies, in addition to the few (mostly case) studies that have been published to date \[[@C20]--[@C22]\], are needed to elucidate the specific mechanisms by which IMT can impact on the interaction between the diaphragm and non-diaphragmatic respiratory muscles during exercise breathing in patients with UDD.

Key points:
-----------

-   Patients with diaphragm dysfunction experience symptoms of exertional dyspnoea.

-   Assessment of pulmonary and respiratory muscle function at rest and during exercise can help to identify abnormalities in breathing characteristics underlying exertional symptoms.

-   IMT might help these patients to improve respiratory muscle function and reduce symptoms on exertion.

-   The effects of IMT on exercise capacity and symptoms in the presented case of a patient with persisting UDD were most probably caused by improvements in non-diaphragmatic respiratory muscle function.

Self-evaluation questions
-------------------------

1.  1\) Which of the listed measurements is the best option to assess isolated diaphragm strength? a) Twitch *P*~di~b) *P*~Imax~c) Sniff *P*~di~d) CMAP

2.  2\) Which of the following observations is typically observed in a patient with UDD? a) Important decrease (\>40%) in FVC measured in supine position relative to FVC obtained in upright positionb) A sniff *P*~di~ \<80 cmH~2~O and a bilateral twitch *P*~di~ \<20 cmH~2~Oc) Severe symptoms of orthopnoead) *P*~Imax~ of \<70% of predicted normal value

3.  3\) IMT may improve exertional dyspnoea in patients with UDD by: a) Improving phrenic nerve conductionb) Increasing isolated diaphragm contractilityc) Increasing non-diaphragmatic inspiratory muscle functiond) Reducing the decrease in FVC in supine position relative to assessments performed in the upright position

Suggested answers
-----------------

1.  1\) a.

2.  2\) b.

3.  3\) c.
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